Pharmaceutical - Financial, Vaccines

Filter

Current filters:

FinancialVaccines

Popular Filters

Changes to the funding access criteria for some vaccines in New Zealand

Changes to the funding access criteria for some vaccines in New Zealand

09-06-2014

New Zealand’s Pharmaceutical Management Agency, PHARMAC, this morning announced changes to the funding…

FinancialHealthcareNew ZealandPharmaceuticalVaccines

Joint purchasing of vaccines and medicines becomes a reality in the EU

Joint purchasing of vaccines and medicines becomes a reality in the EU

10-04-2014

The European Commission today approved a Joint Procurement Agreement, which will enable all European…

Antibiotics and Infectious diseasesEuropeFinancialMarkets & MarketingPharmaceuticalVaccines

Australia’s CSL posts solid half-year results

Australia’s CSL posts solid half-year results

13-02-2014

Australian blood products and vaccine maker CSL reported a 3% rise in net profit to $646 million (all…

CSL LimitedFinancialHematologyPharmaceuticalVaccines

New Zealand views addition of rotavirus, varicella vaccines to national immunization schedule

07-11-2013

A vaccine for the gastric infection rotavirus and protection from varicella for the most vulnerable people…

FinancialHealthcareNew ZealandPfizerPharmaceuticalPrevenarVaccines

HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst

20-05-2013

While the risks involved in HIV vaccine development have turned Big Pharma away from pursuing a preventative…

Anti-viralsBiotechnologyFinancialHVTN 505PharmaceuticalResearchVaccines

Russian government to develop domestic production of vaccines

01-03-2013

The Russian government is considering investing in the domestic production of vaccines, by building a…

EuropeFinancialGenericsPharmaceuticalProductionVaccines

Merck & Co to move HQ as part of cost-savings plan; enters deal with Vaxxas

10-10-2012

US pharma giant Merck & Co (NYSE: MRK) is joining a string of drug majors in announcing cost-cutting…

FinancialLicensingMerck & CoPharmaceuticalVaccinesVaxxas

CSL Biotherapies gets US government contract for flu vaccines

11-09-2012

CSL Biotherapies, a US subsidiary of Australia's CSL (ASX: CSL), one of the world's leading manufacturers…

CSL BiotherapiesCSL LimitedFinancialNorth AmericaPharmaceuticalProductionVaccines

US government adds $32 million to Bavarian Nordic Imvamune contract

22-05-2012

Denmark's Bavarian Nordic (Nasdaq OMX: BAVA) says that the US Department of Health and Human Services…

Bavarian NordicFinancialImvamuneNorth AmericaPharmaceuticalResearchVaccines

EU Commission clears 23 million-euro R&D aid to Novartis Italy for vaccines in developing countries

08-05-2012

The European Commission has concluded that 23 million euros ($30.2 million) public funding, which Italy…

FinancialNovartisPharmaceuticalResearchVaccines

GlaxoSmithKline challenges Argentina court ruling

12-01-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) says it disagrees with the recent court ruling in favor of…

FinancialGlaxoSmithKlineLegalPharmaceuticalSouth AmericaSynflorixVaccines

Stronger incentives for immunization of children in Australia

28-11-2011

Australia’s childhood immunization arrangements are to be reformed with the aim of increasing the…

Asia-PacificFinancialHealthcarePharmaceuticalVaccines

Sanofi oral MS drug Aubagio shows strong efficacy in Ph III trial; plans massive Indian vaccine plant

07-10-2011

French drug major Sanofi (Euronext: SAN) and its subsidiary Genzyme says that the results of a pivotal…

Asia-PacificAubagioFinancialGenzymeNeurologicalPharmaceuticalResearchSanofiShanthaVaccines

Emergent BioSolutions gets $1.25 billion BioThrax order for US government

04-10-2011

Emergent BioSolutions (NYSE: EBS) revealed yesterday that it has received an award to supply the US government…

BioThraxEmergent BioSolutionsFinancialMarkets & MarketingNorth AmericaPharmaceuticalVaccines

Back to top